FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

830160007: Crizanlizumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3880787013 Crizanlizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3880788015 Crizanlizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Crizanlizumab (substance) Has disposition (attribute) Selective adhesion molecule inhibitor true Inferred relationship Some
Crizanlizumab (substance) est un(e) (attribut) Selective adhesion molecule inhibitor true Inferred relationship Some
Crizanlizumab (substance) est un(e) (attribut) Monoclonal immunoglobulin G (substance) true Inferred relationship Some
Crizanlizumab (substance) Has disposition (attribute) Immunomodulator (disposition) true Inferred relationship Some
Crizanlizumab (substance) est un(e) (attribut) anticorps monoclonal chimérique souris-humain d'isotype IgG false Inferred relationship Some
Crizanlizumab (substance) est un(e) (attribut) Immunosuppressant (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only crizanlizumab (medicinal product) a pour principe actif (attribut) True Crizanlizumab (substance) Inferred relationship Some 1
Product containing only crizanlizumab in parenteral dose form (medicinal product form) a pour principe actif (attribut) True Crizanlizumab (substance) Inferred relationship Some 1
Crizanlizumab-containing product in parenteral dose form a pour principe actif (attribut) True Crizanlizumab (substance) Inferred relationship Some 1
Product containing crizanlizumab (medicinal product) a pour principe actif (attribut) True Crizanlizumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start